Gene · 4600
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolutionary history of type II transmembrane serine proteases involved in viral priming. | Hum Genet | 2022 | 35122525 | PubTator, text mining | PubMed |
| Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1. | Curr Opin Virol | 2022 | 35121335 | PubTator, text mining | PubMed |
| Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. | Nat Commun | 2022 | 35115549 | PubTator, text mining | PubMed |
| DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients. | Epigenetics | 2022 | 35094644 | PubTator, text mining | PubMed |
| Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. | J Int Med Res | 2022 | 35086375 | PubTator, text mining | PubMed |
| Antisite defect qubits in monolayer transition metal dichalcogenides. | Nat Commun | 2022 | 35079005 | PubTator, text mining | PubMed |
| Sunscreens with the New MCE Filter Cover the Whole UV Spectrum: Improved UVA1 Photoprotection In Vitro and in a Randomized Controlled Trial. | JID Innov | 2022 | 35072138 | PubTator, text mining | PubMed |
| [(WR)8WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin. | Cells | 2022 | 35053417 | PubTator, text mining | PubMed |
| Multi-dimensional designer catalysts for negative emissions science (NES): bridging the gap between synthesis, simulations, and analysis. | iScience | 2022 | 35036879 | PubTator, text mining | PubMed |
| Theoretical Study of CO Adsorption Interactions with Cr-Doped Tungsten Oxide/Graphene Composites for Gas Sensor Application. | ACS Omega | 2022 | 35036721 | PubTator, text mining | PubMed |
| Predisposition of hypersensitivity in patients with exfoliative cheilitis. | J Dent Sci | 2022 | 35028073 | PubTator, text mining | PubMed |
| Presence of Uterine Leiomyomas Has No Significant Impact on Gene Expression Profile in the Scalp of Patients with Central Centrifugal Cicatricial Alopecia. | JID Innov | 2022 | 35024684 | PubTator, text mining | PubMed |
| Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication. | Nucleic Acids Res | 2022 | 35018437 | PubTator, text mining | PubMed |
| GS-CA1 and lenacapavir stabilize the HIV-1 core and modulate the core interaction with cellular factors. | iScience | 2022 | 35005542 | PubTator, text mining | PubMed |
| Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive. | Sci Rep | 2022 | 34997119 | PubTator, text mining | PubMed |
| Global proteomics of fibroblast cells treated with bacterial cyclic dinucleotides, c-di-GMP and c-di-AMP. | J Oral Microbiol | 2022 | 34992733 | PubTator, text mining | PubMed |
| Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. | Mol Ther Oncolytics | 2022 | 34977342 | PubTator, text mining | PubMed |
| Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters. | Gut Microbes | 2022 | 34965194 | PubTator, text mining | PubMed |
| Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses. | Nat Methods | 2022 | 34949807 | PubTator, text mining | PubMed |
| Local and systemic responses to SARS-CoV-2 infection in children and adults. | Nature | 2022 | 34937051 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4600/papers?page=37